Marshall Wace’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-346,310
Closed -$73.5M 2727
2023
Q3
$73.5M Buy
346,310
+5,903
+2% +$1.18M 0.15% 133
2023
Q2
$65.5M Buy
340,407
+106,604
+46% +$21.2M 0.13% 169
2023
Q1
$47.3M Buy
233,803
+225,397
+2,681% +$36.2M 0.1% 225
2022
Q4
$1.08M Sell
8,406
-135,956
-94% -$17.5M ﹤0.01% 2053
2022
Q3
$19.8M Sell
144,362
-64,506
-31% -$10.5M 0.04% 470
2022
Q2
$37M Sell
208,868
-516,782
-71% -$74.5M 0.08% 272
2022
Q1
$105M Sell
725,650
-671,853
-48% -$90.9M 0.2% 102
2021
Q4
$216M Buy
1,397,503
+440,891
+46% +$73.8M 0.4% 36
2021
Q3
$162M Buy
956,612
+807,977
+544% +$126M 0.67% 13
2021
Q2
$23.5M Sell
148,635
-143,637
-49% -$21.3M 0.11% 202
2021
Q1
$40.6M Buy
292,272
+152,025
+108% +$24.5M 0.19% 108
2020
Q4
$24.6M Buy
140,247
+137,330
+4,708% +$25.6M 0.13% 161
2020
Q3
$571K Sell
2,917
-65,823
-96% -$11M ﹤0.01% 1197
2020
Q2
$11.7M Buy
+68,740
New +$10.3M 0.08% 244
2020
Q1
Sell
-25,017
Closed -$2.86M 2163
2019
Q4
$2.86M Buy
+25,017
New +$2.65M 0.02% 707
2019
Q1
Sell
-8,071
Closed -$457K 2128
2018
Q4
$457K Buy
+8,071
New +$506K ﹤0.01% 1138
2016
Q4
Sell
-40,676
Closed -$2.2M 1153
2016
Q3
$2.2M Buy
+40,676
New +$1.93M 0.02% 575
2015
Q4
Sell
-101,439
Closed -$3.91M 1160
2015
Q3
$3.91M Sell
101,439
-14,622
-13% -$658K 0.05% 334
2015
Q2
$5.62M Buy
+116,061
New +$4.79M 0.07% 283
2014
Q3
Sell
-13,045
Closed -$499K 1079
2014
Q2
$499K Buy
+13,045
New +$493K 0.01% 604

Other funds holding SGEN

Marshall Wace's SGEN Position: Q4 2023 in Review

Marshall Wace sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 346,310 shares — an estimated $73.5M sold.

Marshall Wace first reported a position in SGEN in Q2 2014 and held it in 20 quarters. The position peaked at $216M in Q4 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Marshall Wace reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Marshall Wace sold 346,310 Seagen Inc. Common Stock shares in Q4 2023, an estimated $73.5M.
  • Marshall Wace first reported a position in Seagen Inc. Common Stock in Q2 2014 and held it in 20 quarters.
  • Marshall Wace's Seagen Inc. Common Stock position peaked at $216M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.